Moreover, the Kyoto Encyclopedia of Genes and Genomes antigen processing and presentation score was significantly higher in non-hypermutational samples (< 10 mutations/megabase) in IDH-WT gliomas [43]. This evidence concerns the gene IDH2 and central nervous system cancer.